Medizinische Universität Graz Austria/Österreich - Forschungsportal - Medical University of Graz

Logo MUG-Forschungsportal

Publikationen

Suchbegriffe: CANCER PAIN, . Treffer: 17

2022

Huemer, M; Jahn-Kuch, D; Hofmann, G; Pichler, M A case report of immediate effects of acupuncture on neuropathic cancer breakthrough pain.
Complement Ther Clin Pract. 2022; 48: 101599 Doi: 10.1016/j.ctcp.2022.101599
Web of Science PubMed FullText FullText_MUG

 

2021

Matis, G; De, Negri, P; Dupoiron, D; Likar, R; Zuidema, X; Rasche, D Intrathecal pain management with ziconotide: Time for consensus?
Brain Behav. 2021; 11 Suppl 1: e02055 Doi: 10.1002/brb3.2055 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

Neuwersch-Sommeregger, S; Köstenberger, M; Stettner, H; Pipam, W; Breschan, C; Feigl, G; Likar, R; Egger, M CT-Guided Coeliac Plexus Neurolysis in Patients with Intra-Abdominal Malignancy: A Retrospective Evaluation of 52 Palliative In-Patients.
Pain Ther. 2021; 10(2):1593-1603 Doi: 10.1007/s40122-021-00317-1 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

2019

Jaksch, W; Likar, R; Aigner, M [Ketamine in the therapy of chronic pain and depression].
Wien Med Wochenschr. 2019; 169(15-16): 367-376. Doi: 10.1007/s10354-019-0695-x
Web of Science PubMed FullText FullText_MUG

 

Lang-Illievich, K; Bornemann-Cimenti, H Opioid-induced constipation: a narrative review of therapeutic options in clinical management.
Korean J Pain. 2019; 32(2):69-78 Doi: 10.3344/kjp.2019.32.2.69 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

2013

Davies, A; Buchanan, A; Zeppetella, G; Porta-Sales, J; Likar, R; Weismayr, W; Slama, O; Korhonen, T; Filbet, M; Poulain, P; Mystakidou, K; Ardavanis, A; O'Brien, T; Wilkinson, P; Caraceni, A; Zucco, F; Zuurmond, W; Andersen, S; Damkier, A; Vejlgaard, T; Nauck, F; Radbruch, L; Sjolund, KF; Stenberg, M Breakthrough cancer pain: an observational study of 1000 European oncology patients.
J Pain Symptom Manage. 2013; 46(5): 619-28. Doi: 10.1016/j.jpainsymman.2012.12.009
Web of Science PubMed FullText FullText_MUG

 

Rayment, C; Hjermstad, MJ; Aass, N; Kaasa, S; Caraceni, A; Strasser, F; Heitzer, E; Fainsinger, R; Bennett, MI; European Palliative Care Research Collaborative (EPCRC) Neuropathic cancer pain: prevalence, severity, analgesics and impact from the European Palliative Care Research Collaborative-Computerised Symptom Assessment study.
Palliat Med. 2013; 27(8):714-721 Doi: 10.1177/0269216312464408
Web of Science PubMed FullText FullText_MUG

 

2010

Pergolizzi, J; Aloisi, AM; Dahan, A; Filitz, J; Langford, R; Likar, R; Mercadante, S; Morlion, B; Raffa, RB; Sabatowski, R; Sacerdote, P; Torres, LM; Weinbroum, AA Current knowledge of buprenorphine and its unique pharmacological profile.
Pain Pract. 2010; 10(5): 428-50. Doi: 10.1111/j.1533-2500.2010.00378.x
Web of Science PubMed FullText FullText_MUG

 

Sator-Katzenschlager, S; Fiala, K; Kress, HG; Kofler, A; Neuhold, J; Kloimstein, H; Ilias, W; Mozes-Balla, EM; Pinter, M; Loining, N; Fuchs, W; Heinze, G; Likar, R Subcutaneous target stimulation (STS) in chronic noncancer pain: a nationwide retrospective study.
Pain Pract. 2010; 10(4): 279-86. Doi: 10.1111/j.1533-2500.2009.00351.x
Web of Science PubMed FullText FullText_MUG

 

2009

Reimer, K; Hopp, M; Zenz, M; Maier, C; Holzer, P; Mikus, G; Bosse, B; Smith, K; Buschmann-Kramm, C; Leyendecker, P Meeting the challenges of opioid-induced constipation in chronic pain management - a novel approach.
Pharmacology. 2009; 83(1):10-17 Doi: 10.1159/000165778
Web of Science PubMed FullText FullText_MUG Google Scholar

 

2008

Kusnik, S; Likar, R; Sittl, R Transdermal buprenorphine in chronic pain: indications and clinical experience.
Expert Rev Clin Pharmacol. 2008; 1(6): 729-36. Doi: 10.1586/17512433.1.6.729
PubMed FullText FullText_MUG

 

Pergolizzi, J; Böger, RH; Budd, K; Dahan, A; Erdine, S; Hans, G; Kress, HG; Langford, R; Likar, R; Raffa, RB; Sacerdote, P Opioids and the management of chronic severe pain in the elderly: consensus statement of an International Expert Panel with focus on the six clinically most often used World Health Organization Step III opioids (buprenorphine, fentanyl, hydromorphone, methadone, morphine, oxycodone).
Pain Pract. 2008; 8(4): 287-313. Doi: 10.1111/j.1533-2500.2008.00204.x
PubMed FullText FullText_MUG

 

2007

Kada, O; Likar, R; Pipam, W; Miklautz, M; Janig, H [Cancer pain from the nurses' perspective--findings from Austria].
Pflege Z. 2007; 60(11): 626-30.
PubMed

 

Likar, R; Lorenz, V; Korak-Leiter, M; Kager, I; Sittl, R Transdermal buprenorphine patches applied in a 4-day regimen versus a 3-day regimen: a single-site, Phase III, randomized, open-label, crossover comparison.
Clin Ther. 2007; 29(8): 1591-606. Doi: 10.1016/j.clinthera.2007.08.001
Web of Science PubMed FullText FullText_MUG

 

2006

Likar, R; Kayser, H; Sittl, R Long-term management of chronic pain with transdermal buprenorphine: a multicenter, open-label, follow-up study in patients from three short-term clinical trials.
Clin Ther. 2006; 28(6): 943-52. Doi: 10.1016/j.clinthera.2006.06.012
Web of Science PubMed FullText FullText_MUG

 

2005

Griessinger, N; Sittl, R; Likar, R Transdermal buprenorphine in clinical practice--a post-marketing surveillance study in 13,179 patients.
Curr Med Res Opin. 2005; 21(8):1147-56 Doi: 10.1185/030079905X53315
Web of Science PubMed FullText FullText_MUG

 

Sittl, R; Likar, R; Nautrup, BP Equipotent doses of transdermal fentanyl and transdermal buprenorphine in patients with cancer and noncancer pain: results of a retrospective cohort study.
Clin Ther. 2005; 27(2):225-37 Doi: 10.1016/j.clinthera.2005.02.012
Web of Science PubMed FullText FullText_MUG

 

© Med Uni Graz Impressum